We all have different tolerance levels for how much risk we'll accept when we do a risk vs. reward analysis, says columnist.

Researchers identified a unique protein signature in the blood of BMD and LGMD patients that may reflect disease progression.

Summer can be rough for folks with muscular dystrophy, columnist Patrick Moeschen writes, but it can also bring adventures in ...

Ifetroban improved heart function and reduced cardiac damage biomarkers in people with DMD in a Phase 2 clinical trial.

After a busy year, columnist Betty Vertin is grateful that her three sons with DMD always have one another for socializing.